| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Clinical Professionals is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Established in 1988, Health Design Plus (HDP) initially a Care Management company, expanded its suite of services to include network development/management and claims administration. With over 25 years of continued success, Health Design Plus continues to offer new products, such as Good Health by Design®, a suite of Wellness programs including LifeStart®, a Maternity Management program, Wellness Counts®, a biometric screening and coaching program, Carewise®, a Care Management program, and Healthy Living™, a Disease Management program, designed to fit all wellness-readiness levels, promoting healthier lifestyle choices and behavior modification to reach personal goals. Health Design Plus helps clients fuel their fiscal health in the marketplace while improving the health of their employees and members. Recently, HDP has gained national recognition as the industry leader in Domestic Travel Surgery programs with the launch of CliniFIT™ Centers of Excellence. HDP`s CliniFIT™ Centers of Excellence programs offer employers unparalleled commitment to consistently deliver safe, effective, evidence-based care. Qualified employees have access to recognized leaders in specific fields of medicine, Cardiac, Spine and Joint Replacement.
Incapital was founded in 1999 with the mission of providing securities firms and individual investors more efficient access to corporate bonds. While Incapital`s expertise in underwriting and distributing investment-grade corporate bonds remains a core competency, the firm now originates and distributes offerings across multiple asset classes. In addition to its broker-dealer and bank partners, Incapital now serves institutional investors and wealth managers. With over 150 employees in multiple offices in North America, the firm represents over 400 issuing entities and serves 800+ distribution partners. Incapital continues to provide market leadership with a growing range of product offerings, strong strategic partnerships and innovative technology.
Richman Root Delaney MD is a Waterford, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.